Paper3914545
A review of metabolite kinetics.
Pang KS. J Pharmacokinet Biopharm, 1985. Cited by 70 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. A review of metabolite kinetics. Papers, record 3914545. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3914545
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Pharmaceutical Preparations | Major topic |
| Animals | |
| Biotransformation | |
| Humans | |
| Injections, Intravenous | |
| Kinetics | |
| Liver |
Source PubMed
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7,288,602 | Dose- and time-dependent elimination of acetaminophen in rats: pharmacokinetic implications of cosubstrate depletion. | J Pharmacol Exp Ther | 1981 | https://conductscience.org/library/papers/7288602 | PubMed |
| 2 | 6,106,488 | Pharmacokinetics of benzodiazepines. Short-acting versus long-acting. | Arzneimittelforschung | 1980 | https://conductscience.org/library/papers/6106488 | PubMed |
| 3 | 641,815 | Theoretical relationships between area under the curve and route of administration of drugs and their precursors for evaluating sites and pathways of metabolism. | J Pharm Sci | 1978 | https://conductscience.org/library/papers/641815 | PubMed |
| 4 | 480,149 | Sequential first-pass elimination of a metabolite derived from a precursor. | J Pharmacokinet Biopharm | 1979 | https://conductscience.org/library/papers/480149 | PubMed |
| 5 | 6,032,052 | Kinetic considerations relating to the accrual and elimination of drug metabolites. | Br J Pharmacol Chemother | 1967 | https://conductscience.org/library/papers/6032052 | PubMed |
| 6 | 978,394 | Pharmacokinetics of isoniazid and some metabolites in man. | J Pharmacokinet Biopharm | 1976 | https://conductscience.org/library/papers/978394 | PubMed |
| 7 | 2,858,375 | Metabolism of acetaminophen and phenacetin by isolated rat hepatocytes. A system in which the spatial organization inherent in the liver is disrupted. | Drug Metab Dispos | 1985 | https://conductscience.org/library/papers/2858375 | PubMed |
| 8 | 731,406 | A theoretical examination of the effects of gut wall metabolism, hepatic elimination, and enterohepatic recycling on estimates of bioavailability and of hepatic blood flow. | J Pharmacokinet Biopharm | 1978 | https://conductscience.org/library/papers/731406 | PubMed |
| 9 | 14,098,474 | EXCRETION AND THE ACCRUAL OF DRUG METABOLITES. | Nature | 1963 | https://conductscience.org/library/papers/14098474 | PubMed |
| 10 | 6,034,239 | Treatment of data from drug urinary excretion. | Nature | 1967 | https://conductscience.org/library/papers/6034239 | PubMed |
| 11 | 7,310,646 | Metabolite to parent drug concentration ratio as a function of parent drug extraction ratio: cases of nonportal route of administration. | J Pharmacokinet Biopharm | 1981 | https://conductscience.org/library/papers/7310646 | PubMed |
| 12 | 100,595 | Pharmacokinetics of carbamazepine-10,11- epoxide before and after autoinduction in rhesus monkeys. | J Pharmacol Exp Ther | 1978 | https://conductscience.org/library/papers/100595 | PubMed |
| 13 | 7,288,601 | Aberrant Pharmacokinetics of harmol in the perfused rat liver preparation: sulfate and glucuronide conjugations. | J Pharmacol Exp Ther | 1981 | https://conductscience.org/library/papers/7288601 | PubMed |
| 14 | 7,144,740 | Rates of sulfation and glucuronidation of 7-hydroxycoumarin in periportal and pericentral regions of the liver lobule. | Mol Pharmacol | 1982 | https://conductscience.org/library/papers/7144740 | PubMed |
| 15 | 6,102,028 | Metabolite pharmacokinetics: methods for simultaneous estimates of elimination rate constants of a drug and its metabolite. A commentary. | Drug Metab Dispos | 1980 | https://conductscience.org/library/papers/6102028 | PubMed |
| 16 | 5,416,180 | Two-compartment model for a drug and its metabolite: application to acetylsalicylic acid pharmacokinetics. | J Pharm Sci | 1970 | https://conductscience.org/library/papers/5416180 | PubMed |
| 17 | 4,032,242 | General method for evaluating the fraction of the irreversible organ clearance due to conversion of drug to a primary metabolite. | J Pharm Sci | 1985 | https://conductscience.org/library/papers/4032242 | PubMed |
| 18 | 7,048,351 | Drug metabolite kinetics. | Pharmacol Ther | 1981 | https://conductscience.org/library/papers/7048351 | PubMed |
| 19 | 7,252,793 | Symbols in pharmacokinetics. | J Pharmacokinet Biopharm | 1980 | https://conductscience.org/library/papers/7252793 | PubMed |
| 20 | 702,339 | Kinetics of metabolite formation and elimination in the perfused rat liver preparation: differences between the elimination of preformed acetaminophen and acetaminophen formed from phenacetin. | J Pharmacol Exp Ther | 1978 | https://conductscience.org/library/papers/702339 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 70 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40,264,990 | Pharmacokinetics of cannabidiol, (-)-trans-Δ9-tetrahydrocannabinol, and their oxidative metabolites after intravenous and oral administration of a cannabidiol-dominant full-spectrum hemp product to beagle dogs. | Front Vet Sci | 2025 | https://conductscience.org/library/papers/40264990 | PubMed |
| 32,055,581 | Understanding the pharmacokinetics of reversible metabolism. | Transl Clin Pharmacol | 2019 | https://conductscience.org/library/papers/32055581 | PubMed |
| 32,055,540 | Understanding the pharmacokinetics of prodrug and metabolite. | Transl Clin Pharmacol | 2018 | https://conductscience.org/library/papers/32055540 | PubMed |
| 22,807,110 | In vivo-formed versus preformed metabolite kinetics of trans-resveratrol-3-sulfate and trans-resveratrol-3-glucuronide. | Drug Metab Dispos | 2012 | https://conductscience.org/library/papers/22807110 | PubMed |
| 21,153,869 | Physiologically-based pharmacokinetic modeling for absorption, transport, metabolism and excretion. | J Pharmacokinet Pharmacodyn | 2010 | https://conductscience.org/library/papers/21153869 | PubMed |
| 11,587,492 | A physiologically based pharmacokinetic analysis of capecitabine, a triple prodrug of 5-FU, in humans: the mechanism for tumor-selective accumulation of 5-FU. | Pharm Res | 2001 | https://conductscience.org/library/papers/11587492 | PubMed |
| 9,625,274 | Pharmacokinetics of a nootropic agent, BMY-21502, and its metabolites in beagle dogs. | Eur J Drug Metab Pharmacokinet | 1998 | https://conductscience.org/library/papers/9625274 | PubMed |
| 9,561,490 | Metabolite mean transit times in the liver as predicted by various models of hepatic elimination. | J Pharmacokinet Biopharm | 1997 | https://conductscience.org/library/papers/9561490 | PubMed |
| 3,259,856 | Pharmacokinetic advantages of erythromycin estolate over ethylsuccinate as determined by high-pressure liquid chromatography. | Antimicrob Agents Chemother | 1988 | https://conductscience.org/library/papers/3259856 | PubMed |
| 3,199,316 | Primary, secondary, and tertiary metabolite kinetics. | J Pharmacokinet Biopharm | 1988 | https://conductscience.org/library/papers/3199316 | PubMed |
| 2,715,930 | An area function method for calculating the apparent elimination rate constant of a metabolite. | J Pharmacokinet Biopharm | 1989 | https://conductscience.org/library/papers/2715930 | PubMed |
| 2,469,080 | Metabolite formation pharmacokinetics: rate and extent of metabolite formation determined by deconvolution. | Pharm Res | 1988 | https://conductscience.org/library/papers/2469080 | PubMed |
| 2,379,537 | Nonlinear kinetics of propafenone metabolites in healthy man. | Eur J Clin Pharmacol | 1990 | https://conductscience.org/library/papers/2379537 | PubMed |
| 2,335,047 | Use of metabolite AUC data in bioavailability studies to discriminate between absorption and first-pass extraction. | Clin Pharmacokinet | 1990 | https://conductscience.org/library/papers/2335047 | PubMed |
| 2,266,497 | Physiological modeling of drug and metabolite: disposition of oxazepam and oxazepam glucuronides in the recirculating perfused mouse liver preparation. | J Pharmacokinet Biopharm | 1990 | https://conductscience.org/library/papers/2266497 | PubMed |
| 1,875,284 | An initial slope method for model structure: independent estimation of the elimination rate constant of a metabolite. | J Pharmacokinet Biopharm | 1991 | https://conductscience.org/library/papers/1875284 | PubMed |
| 1,409,378 | Pharmacokinetic analysis of the structural requirements for forming "stable" analogues of valpromide. | Pharm Res | 1992 | https://conductscience.org/library/papers/1409378 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3914545
GET https://conductscience.org/api/papers/v1/3914545/references?page=2